Neha Singla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Neha Singla has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Devinder Kumar Dhawan
Department of Biophysics, Panjab University, Chandigarh, India
9 shared publications - Ravi Pratap Barnwal
Department of Biophysics, Panjab University
4 shared publications Ananya Shukla
Department of Biophysics, Panjab University, Chandigarh, India
3 shared publications- Gurpal Singh
Panjab University
3 shared publications Akanksha Sharma
Univesity Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
2 shared publications- Ashish Suttee
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
2 shared publications
Latest Publications
- 27 February 2023
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (6) , 2491-2523
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
The development of early non-invasive diagnosis methods and identification of novel biomarkers are necessary for managing Alzheimer’s disease (AD) and facilitating effective prognosis and treatment. AD has multi-factorial nature and involves complex molecular mechanism, which causes neuronal degeneration. The primary challenges in early AD detection include patient heterogeneity and lack of precise diagnosis at the preclinical stage. Several cerebrospinal fluid (CSF) and blood biomarkers have been proposed to show excellent diagnosis ability by identifying tau pathology and cerebral amyloid beta (Aβ) for AD. Intense research endeavors are being made to develop ultrasensitive detection techniques and find potent biomarkers for early AD diagnosis. To mitigate AD worldwide, understanding various CSF biomarkers, blood biomarkers, and techniques that can be used for early diagnosis is imperative. This review attempts to provide information regarding AD pathophysiology, genetic and non-genetic factors associated with AD, several potential blood and CSF biomarkers, like neurofilament light, neurogranin, Aβ, and tau, along with biomarkers under development for AD detection. Besides, numerous techniques, such as neuroimaging, spectroscopic techniques, biosensors, and neuroproteomics, which are being explored to aid early AD detection, have been discussed. The insights thus gained would help in finding potential biomarkers and suitable techniques for the accurate diagnosis of early AD before cognitive dysfunction. Graphical Abstract
- 27 February 2023
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (6) , 2491-2523
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
The development of early non-invasive diagnosis methods and identification of novel biomarkers are necessary for managing Alzheimer’s disease (AD) and facilitating effective prognosis and treatment. AD has multi-factorial nature and involves complex molecular mechanism, which causes neuronal degeneration. The primary challenges in early AD detection include patient heterogeneity and lack of precise diagnosis at the preclinical stage. Several cerebrospinal fluid (CSF) and blood biomarkers have been proposed to show excellent diagnosis ability by identifying tau pathology and cerebral amyloid beta (Aβ) for AD. Intense research endeavors are being made to develop ultrasensitive detection techniques and find potent biomarkers for early AD diagnosis. To mitigate AD worldwide, understanding various CSF biomarkers, blood biomarkers, and techniques that can be used for early diagnosis is imperative. This review attempts to provide information regarding AD pathophysiology, genetic and non-genetic factors associated with AD, several potential blood and CSF biomarkers, like neurofilament light, neurogranin, Aβ, and tau, along with biomarkers under development for AD detection. Besides, numerous techniques, such as neuroimaging, spectroscopic techniques, biosensors, and neuroproteomics, which are being explored to aid early AD detection, have been discussed. The insights thus gained would help in finding potential biomarkers and suitable techniques for the accurate diagnosis of early AD before cognitive dysfunction. Graphical Abstract
- Open Access
- 1 July 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 26, 100962
Fluorescent quantum dots: An insight on synthesis and potential biological application as drug carrier in cancer
- 1 July 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 26, 100962
Open AccessFluorescent quantum dots: An insight on synthesis and potential biological application as drug carrier in cancer
- Top Cited Papers
- 1 September 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 201, 110812
Global trends in pesticides: A looming threat and viable alternatives
- 1 September 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 201, 110812
Top Cited PapersGlobal trends in pesticides: A looming threat and viable alternatives
- Open Access
CYCLODEXTRIN DERIVATIVE ENHANCES THE OPHTHALMIC DELIVERY OF POORLY SOLUBLE AZITHROMYCIN
Azithromycin (AZM), a macrolide antibiotic used for the treatment of Chlamydial conjunctivitis, is less effective for the treatment of this disease due to its poor bioavailability (38%). Various alternatives have been developed for improving the physico-chemical properties (i.e., solubility) of the AZM without much success. To overcome the problems associated with AZM, an inclusion complex employing a modified cyclodextrin i.e., sulfobutylether-β-cyclodextrin (SBE-β-CD) was prepared and characterized by phase solubility studies, pXRD and FTIR techniques. The results portrayed the formation of the inclusion complex of AZM with sulfobutylether β-cyclodextrin (SBE-β-CD) in 1:2 molar stoichiometric ratios. This inclusion complex was later incorporated into a polymer matrix to prepare an in situ gel. Various combinations of carbopol 934P and hydroxypropyl methylcellulose (HPMC K4M) polymers were used and evaluated by rheological and in vitro drug release studies. The optimized formulation (F4), containing carbopol 934P 0.2% (w/v) and HPMC K4M 0.2% (w/v), was evaluated for clarity, pH, gelling capacity, drug content, rheological properties, in vitro drug release pattern, ocular irritation test and antimicrobial efficacy. Finally, owing to the improved antimicrobial efficacy and increased residence time, AZM:SBE-β-CD in situ gel was found to be a promising formulation for the efficient treatment of bacterial ocular disease.
Open AccessCYCLODEXTRIN DERIVATIVE ENHANCES THE OPHTHALMIC DELIVERY OF POORLY SOLUBLE AZITHROMYCIN
Azithromycin (AZM), a macrolide antibiotic used for the treatment of Chlamydial conjunctivitis, is less effective for the treatment of this disease due to its poor bioavailability (38%). Various alternatives have been developed for improving the physico-chemical properties (i.e., solubility) of the AZM without much success. To overcome the problems associated with AZM, an inclusion complex employing a modified cyclodextrin i.e., sulfobutylether-β-cyclodextrin (SBE-β-CD) was prepared and characterized by phase solubility studies, pXRD and FTIR techniques. The results portrayed the formation of the inclusion complex of AZM with sulfobutylether β-cyclodextrin (SBE-β-CD) in 1:2 molar stoichiometric ratios. This inclusion complex was later incorporated into a polymer matrix to prepare an in situ gel. Various combinations of carbopol 934P and hydroxypropyl methylcellulose (HPMC K4M) polymers were used and evaluated by rheological and in vitro drug release studies. The optimized formulation (F4), containing carbopol 934P 0.2% (w/v) and HPMC K4M 0.2% (w/v), was evaluated for clarity, pH, gelling capacity, drug content, rheological properties, in vitro drug release pattern, ocular irritation test and antimicrobial efficacy. Finally, owing to the improved antimicrobial efficacy and increased residence time, AZM:SBE-β-CD in situ gel was found to be a promising formulation for the efficient treatment of bacterial ocular disease.
- Open Access
- 1 March 2020
- Published by Walter de Gruyter GmbH in Interdisciplinary Toxicology
- Vol. 13 (1) , 39-47
Modulatory role of quercetin against chlorpyrifos induced blood toxicity in rats
Chlorpyrifos (CPF) is a broad-spectrum organophosphate insecticide and has been reported to cause a number of serious deleterious effects on physiological systems. The present study was designed to evaluate the role of quercetin (QC) during CPF induced toxicity in blood cells. Female Wistar rats weighing 150–200 g were divided into four different groups viz: Normal Control, CPF treated (13.5 mg/kg body weight every alternate day), QC treated (50 mg/kg body weight/day) and combined CPF + QC treated. The effects of different treatments were studied on various hematological parameters as well as on anti-oxidant defense system. CPF treated animals showed a significant decrease in total leukocyte counts (TLC), lymphocyte counts, hemoglobin (Hb) levels and aminolevulinic acid dehydratase (ALAD) activity, which however showed appreciable improvement upon simultaneous treatment with QC. Contrarily, neutrophils counts were found to be significantly increased, which, however, were decreased upon simultaneous treatment with QC. Further, CPF exposure caused a significant increase in the levels of lipid peroxidation (LPO) and protein carbonyl content (PCC) as well as increased the activities of super oxide dismutase (SOD) and catalase (CAT) in blood, which were decreased on QC co-treatment. Moreover, CPF treatment also caused inhibition of glutathione system in blood but QC co-treatment was able to up-regulate the glutathione system. Therefore, the present study, suggests that QC unveils a protective potential in containing CPF induced blood toxicity.
- 1 March 2020
- Published by Walter de Gruyter GmbH in Interdisciplinary Toxicology
- Vol. 13 (1) , 39-47
Open AccessModulatory role of quercetin against chlorpyrifos induced blood toxicity in rats
Chlorpyrifos (CPF) is a broad-spectrum organophosphate insecticide and has been reported to cause a number of serious deleterious effects on physiological systems. The present study was designed to evaluate the role of quercetin (QC) during CPF induced toxicity in blood cells. Female Wistar rats weighing 150–200 g were divided into four different groups viz: Normal Control, CPF treated (13.5 mg/kg body weight every alternate day), QC treated (50 mg/kg body weight/day) and combined CPF + QC treated. The effects of different treatments were studied on various hematological parameters as well as on anti-oxidant defense system. CPF treated animals showed a significant decrease in total leukocyte counts (TLC), lymphocyte counts, hemoglobin (Hb) levels and aminolevulinic acid dehydratase (ALAD) activity, which however showed appreciable improvement upon simultaneous treatment with QC. Contrarily, neutrophils counts were found to be significantly increased, which, however, were decreased upon simultaneous treatment with QC. Further, CPF exposure caused a significant increase in the levels of lipid peroxidation (LPO) and protein carbonyl content (PCC) as well as increased the activities of super oxide dismutase (SOD) and catalase (CAT) in blood, which were decreased on QC co-treatment. Moreover, CPF treatment also caused inhibition of glutathione system in blood but QC co-treatment was able to up-regulate the glutathione system. Therefore, the present study, suggests that QC unveils a protective potential in containing CPF induced blood toxicity.
- 12 February 2019
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 42 (2) , 220-230
Neuro-protective potential of quercetin during chlorpyrifos induced neurotoxicity in rats
Chlorpyrifos (CPF) has been considered as one of the most potent organophosphates and is linked to several neurological disorders. On the other hand, Quercetin is a vital plant flavanoid and has been reported to regulate a number of physiological processes in the central nervous system. The present study was conducted to investigate the protective potential of quercetin during chlorpyrifos induced neurotoxicity. Female Wistar rats weighing 150–200 g were divided into four different groups viz: Normal control, CPF treated (13.5 mg/kg.b.wt. every alternate day), Quercetin treated (50 mg/kg.b.wt./day) and combined CPF and quercetin-treated. All the treatments were carried out for a total duration of eight weeks. Chlorpyrifos treatment showed significant alterations in the cognitive behavior and motor activities of rats, which were appreciably improved upon simultaneous supplementation with quercetin. Further, CPF treatment caused a significant inhibition in the enzyme activities of acetylcholinesterase and choline acetyltransferase, but caused an increase in the levels of acetylcholine in the brain. Further, chlorpyrifos exposure significantly elevated the levels of lipid peroxidation and protein carbonyl contents as well as the activities of catalase, superoxide dismutase, which were interestingly found to be decreased following co-treatment with quercetin. In contrast, CPF treatment decreased the activities of glutathione reductase, transferase, as well as levels of reduced and total glutathione in both the cerebrum and cerebellum but co-administration of quercetin, increased these levels. Chlorpyrifos treatment altered the neuro-histoarchitecture, which showed improvement upon quercetin supplementation. Hence, this study suggests that quercetin can be used as a prophylactic intervention to prevent CPF induced neurotoxicity.
- 12 February 2019
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 42 (2) , 220-230
Neuro-protective potential of quercetin during chlorpyrifos induced neurotoxicity in rats
Chlorpyrifos (CPF) has been considered as one of the most potent organophosphates and is linked to several neurological disorders. On the other hand, Quercetin is a vital plant flavanoid and has been reported to regulate a number of physiological processes in the central nervous system. The present study was conducted to investigate the protective potential of quercetin during chlorpyrifos induced neurotoxicity. Female Wistar rats weighing 150–200 g were divided into four different groups viz: Normal control, CPF treated (13.5 mg/kg.b.wt. every alternate day), Quercetin treated (50 mg/kg.b.wt./day) and combined CPF and quercetin-treated. All the treatments were carried out for a total duration of eight weeks. Chlorpyrifos treatment showed significant alterations in the cognitive behavior and motor activities of rats, which were appreciably improved upon simultaneous supplementation with quercetin. Further, CPF treatment caused a significant inhibition in the enzyme activities of acetylcholinesterase and choline acetyltransferase, but caused an increase in the levels of acetylcholine in the brain. Further, chlorpyrifos exposure significantly elevated the levels of lipid peroxidation and protein carbonyl contents as well as the activities of catalase, superoxide dismutase, which were interestingly found to be decreased following co-treatment with quercetin. In contrast, CPF treatment decreased the activities of glutathione reductase, transferase, as well as levels of reduced and total glutathione in both the cerebrum and cerebellum but co-administration of quercetin, increased these levels. Chlorpyrifos treatment altered the neuro-histoarchitecture, which showed improvement upon quercetin supplementation. Hence, this study suggests that quercetin can be used as a prophylactic intervention to prevent CPF induced neurotoxicity.
- 6 March 2017
- Published by Springer Nature in Biological Trace Element Research
- Vol. 179 (2) , 247-258
Evidence of Zinc in Affording Protection Against X-Ray-Induced Brain Injury in Rats
In the present world, X-rays have been regarded as one of the most efficient tools in medicine, industry and research. On the contrary, extensive human exposure to these rays is responsible for causing detrimental effects on physiological system. The aim of the present study was to investigate the role of zinc (Zn), if any, in mitigating the adverse effects induced by fractionated X-irradiation on rat brain. Female Sprague-Dawley rats weighing 170–200 g were divided into four different groups viz.: (a) normal control, (b) X-irradiated (21Gy), (c) zinc treated (227 mg/L in drinking water) and (d) X-irradiated + zinc treated. The skulls of animals belonging to groups (b) and (d) were exposed to X-rays in 30 fractions. Each fraction delivered a radiation dose of 70 rads, and rats were exposed to two fractions every day for 15 days, consecutively. X-ray treatment resulted in significant alterations in the neurobehavior, neurotransmitter levels and neuro-histoarchitecture of rats, whereas zinc co-treatment with X-rays resulted in significant improvement in these parameters. X-ray exposure also caused a significant increase in the levels of lipid peroxidation as well as activities of catalase and superoxide dismutase, which however were decreased upon simultaneous Zn treatment. On the contrary, X-ray treatment down-regulated the glutathione system, which were found to be up-regulated by zinc co-treatment. Further, protein expressions of p53 and NF-ҚB were found to be significantly elevated after X-irradiation, which were reversed following Zn supplementation. Hence, Zn seems to be an effective agent in mitigating the detrimental effects caused by exposure to X-rays.
- 6 March 2017
- Published by Springer Nature in Biological Trace Element Research
- Vol. 179 (2) , 247-258
Evidence of Zinc in Affording Protection Against X-Ray-Induced Brain Injury in Rats
In the present world, X-rays have been regarded as one of the most efficient tools in medicine, industry and research. On the contrary, extensive human exposure to these rays is responsible for causing detrimental effects on physiological system. The aim of the present study was to investigate the role of zinc (Zn), if any, in mitigating the adverse effects induced by fractionated X-irradiation on rat brain. Female Sprague-Dawley rats weighing 170–200 g were divided into four different groups viz.: (a) normal control, (b) X-irradiated (21Gy), (c) zinc treated (227 mg/L in drinking water) and (d) X-irradiated + zinc treated. The skulls of animals belonging to groups (b) and (d) were exposed to X-rays in 30 fractions. Each fraction delivered a radiation dose of 70 rads, and rats were exposed to two fractions every day for 15 days, consecutively. X-ray treatment resulted in significant alterations in the neurobehavior, neurotransmitter levels and neuro-histoarchitecture of rats, whereas zinc co-treatment with X-rays resulted in significant improvement in these parameters. X-ray exposure also caused a significant increase in the levels of lipid peroxidation as well as activities of catalase and superoxide dismutase, which however were decreased upon simultaneous Zn treatment. On the contrary, X-ray treatment down-regulated the glutathione system, which were found to be up-regulated by zinc co-treatment. Further, protein expressions of p53 and NF-ҚB were found to be significantly elevated after X-irradiation, which were reversed following Zn supplementation. Hence, Zn seems to be an effective agent in mitigating the detrimental effects caused by exposure to X-rays.
- 1 October 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 80, 82-90
Low dose X-irradiation mitigates diazepam induced depression in rat brain
- 1 October 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 80, 82-90
Low dose X-irradiation mitigates diazepam induced depression in rat brain
- 7 January 2016
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (1) , 406-422
Zinc Improves Cognitive and Neuronal Dysfunction During Aluminium-Induced Neurodegeneration
Metals are considered as important components of a physiologically active cell, and imbalance in their levels can lead to various diseased conditions. Aluminium (Al) is an environmental neurotoxicant, which is etiologically related to several neurodegenerative disorders like Alzheimer’s, whereas zinc (Zn) is an essential trace element that regulates a large number of metabolic processes in the brain. The objective of the present study was to understand whether Zn provides any physiological protection during Al-induced neurodegeneration. Male Sprague Dawley rats weighing 140–160 g received either aluminium chloride (AlCl3) orally (100 mg/kg b.wt./day), zinc sulphate (ZnSO4) in drinking water (227 mg/L) or combined treatment of aluminium and zinc for 8 weeks. Al treatment resulted in a significant decline in the cognitive behaviour of rats, whereas zinc supplementation caused an improvement in various neurobehavior parameters. Further, Al exposure decreased (p ≤ 0.001) the levels of neurotransmitters, acetylcholinesterase activity, but increased (p ≤ 0.001) the levels of l-citrulline as well as activities of nitric oxide and monoamine oxidase in the brain. However, zinc administration to Al-treated animals increased the levels of neurotransmitters and regulated the altered activities of brain markers. Western blot of tau, amyloid precursor protein (APP), glial fibrillary acidic protein (GFAP), ubiquitin, α-synuclein and Hsp 70 were also found to be elevated after Al exposure, which however were reversed following Zn treatment. Al treatment also revealed alterations in neurohistoarchitecture in the form of loss of pyramidal and Purkinje cells, which were improved upon zinc co-administration. Therefore, the present study demonstrates that zinc improves cognitive functions by regulating α-synuclein and APP-mediated molecular pathways during aluminium-induced neurodegeneration.
- 7 January 2016
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (1) , 406-422
Zinc Improves Cognitive and Neuronal Dysfunction During Aluminium-Induced Neurodegeneration
Metals are considered as important components of a physiologically active cell, and imbalance in their levels can lead to various diseased conditions. Aluminium (Al) is an environmental neurotoxicant, which is etiologically related to several neurodegenerative disorders like Alzheimer’s, whereas zinc (Zn) is an essential trace element that regulates a large number of metabolic processes in the brain. The objective of the present study was to understand whether Zn provides any physiological protection during Al-induced neurodegeneration. Male Sprague Dawley rats weighing 140–160 g received either aluminium chloride (AlCl3) orally (100 mg/kg b.wt./day), zinc sulphate (ZnSO4) in drinking water (227 mg/L) or combined treatment of aluminium and zinc for 8 weeks. Al treatment resulted in a significant decline in the cognitive behaviour of rats, whereas zinc supplementation caused an improvement in various neurobehavior parameters. Further, Al exposure decreased (p ≤ 0.001) the levels of neurotransmitters, acetylcholinesterase activity, but increased (p ≤ 0.001) the levels of l-citrulline as well as activities of nitric oxide and monoamine oxidase in the brain. However, zinc administration to Al-treated animals increased the levels of neurotransmitters and regulated the altered activities of brain markers. Western blot of tau, amyloid precursor protein (APP), glial fibrillary acidic protein (GFAP), ubiquitin, α-synuclein and Hsp 70 were also found to be elevated after Al exposure, which however were reversed following Zn treatment. Al treatment also revealed alterations in neurohistoarchitecture in the form of loss of pyramidal and Purkinje cells, which were improved upon zinc co-administration. Therefore, the present study demonstrates that zinc improves cognitive functions by regulating α-synuclein and APP-mediated molecular pathways during aluminium-induced neurodegeneration.
- 9 November 2014
- Published by Springer Nature in BioMetals
- Vol. 28 (1) , 61-73
Zinc down regulates Apaf-1-dependent Bax/Bcl-2 mediated caspases activation during aluminium induced neurotoxicity
Aluminium (Al), a ubiquitous element in nature is associated with the onset of Alzheimer’s disease. On the other hand, zinc (Zn) is an essential trace element that regulates large number of physiological processes in the human body. The present study was conducted to explore the role of zinc, if any, in regulating apoptotic machinery during Al induced neurodegeneration in rat. Male sprague dawley rats weighing 140–160 g were divided into four different groups viz: Normal control, Al treated (100 mg/kg b.wt./day), Zn treated (227 mg/l) and combined Al and Zn treated. All the treatments were carried out for a total duration of 8 weeks. Al treatment resulted in a significant increase in the protein expressions of cytochrome c, Bax, Apaf-1, caspase 9, caspase 3 (p17), caspase 8, caspase 6, caspase 7 but decreased the Bcl-2 in both the cerebrum and cerebellum. However, Zn supplementation to Al treated rats resulted in a reduction in the protein expressions of cytochrome c, Bax, Apaf-1, caspase 9, caspase 3 (p17), caspase 8, caspase 6 and caspase 7 whereas it elevated the Bcl-2 in both the regions. Further, gene expressions of caspase 3 and caspase 9 were also found to be elevated after Al treatment, which however were reduced following Zn co-treatment. The electron-microscopic analysis of brain revealed that Al intoxication resulted in a number of degenerative signs at ultrastructural level, which were appreciably improved upon Zn supplementation. The present study suggests that Zn provides protection against Al induced neurotoxicity by triggering anti-apoptotic machinery.
- 9 November 2014
- Published by Springer Nature in BioMetals
- Vol. 28 (1) , 61-73
Zinc down regulates Apaf-1-dependent Bax/Bcl-2 mediated caspases activation during aluminium induced neurotoxicity
Aluminium (Al), a ubiquitous element in nature is associated with the onset of Alzheimer’s disease. On the other hand, zinc (Zn) is an essential trace element that regulates large number of physiological processes in the human body. The present study was conducted to explore the role of zinc, if any, in regulating apoptotic machinery during Al induced neurodegeneration in rat. Male sprague dawley rats weighing 140–160 g were divided into four different groups viz: Normal control, Al treated (100 mg/kg b.wt./day), Zn treated (227 mg/l) and combined Al and Zn treated. All the treatments were carried out for a total duration of 8 weeks. Al treatment resulted in a significant increase in the protein expressions of cytochrome c, Bax, Apaf-1, caspase 9, caspase 3 (p17), caspase 8, caspase 6, caspase 7 but decreased the Bcl-2 in both the cerebrum and cerebellum. However, Zn supplementation to Al treated rats resulted in a reduction in the protein expressions of cytochrome c, Bax, Apaf-1, caspase 9, caspase 3 (p17), caspase 8, caspase 6 and caspase 7 whereas it elevated the Bcl-2 in both the regions. Further, gene expressions of caspase 3 and caspase 9 were also found to be elevated after Al treatment, which however were reduced following Zn co-treatment. The electron-microscopic analysis of brain revealed that Al intoxication resulted in a number of degenerative signs at ultrastructural level, which were appreciably improved upon Zn supplementation. The present study suggests that Zn provides protection against Al induced neurotoxicity by triggering anti-apoptotic machinery.